Alembic Pharmaceuticals has received tentative approval from the US Food & Drug Administration (USFDA) for Bosutinib Tablets, 100 mg and 500 mg.
Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.